---
title: "ABVC BioPharma (ABVC.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ABVC.US/norm.md"
symbol: "ABVC.US"
name: "ABVC BioPharma"
parent: "https://longbridge.com/zh-CN/quote/ABVC.US.md"
datetime: "2026-05-22T01:36:07.089Z"
locales:
  - [en](https://longbridge.com/en/quote/ABVC.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ABVC.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ABVC.US/norm.md)
---

# ABVC BioPharma (ABVC.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0613 | -0.1471 | -0.0536 | -0.1298 | -0.0563 |
| ROE | -57.04% | -123.02% | -52.29% | -145.40% | -101.60% |
| 营业收入 | - | -795950.00 | 795950.00 | - | - |
| 净利润 | -1.56M | -3.56M | -1.25M | -2.26M | -842075.00 |
| 营业利润 | -1.57M | -2.99M | -1.17M | -2.29M | -693005.00 |
| 毛利率 | - | 100.00% | 100.00% | - | - |
| 净利率 | - | 447.63% | -156.61% | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 19.73M | 21.06M | 21.18M | 16.24M | 14.88M |
| 权益乘数 | 1.54 | 1.58 | 1.46 | 1.71 | 1.87 |
| 每股净资产 | 0.4181 | 0.4569 | 0.5140 | 0.3730 | 0.3690 |
| 资产周转率 | - | - | 0.0448 | 0.0253 | 0.0347 |
| 现金及短投 | 202509.00 | 745834.00 | 257243.00 | 453462.00 | 217258.00 |
| 存货与应收 | - | - | 11460.00 | 11460.00 | 11460.00 |
| 长期投资 | 14.65M | 14.75M | 12.42M | 8.67M | 8.70M |
| 净债务 | 2.53M | 2.73M | 2.21M | 1.72M | 2.66M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -894243.00 | -1.42M | -133257.00 | -894174.00 | -539833.00 |
| 投资现金流 | 47123.00 | 730346.00 | -1.27M | -665779.00 | - |
| 融资现金流 | -342181.00 | 1.15M | 1.13M | 1.93M | 428756.00 |
| 自由现金流 | 1.09M | 1.88M | -1.33M | -328826.00 | 761235.00 |
| 现金流充裕率 | -135.15% | -1305.87% | -39.70% | -1206.81% | -1845.58% |
| 举债与偿债 | - | 730000.00 | 150000.00 | 9010.00 | - |
| 资本支出 | - | - | - | - | - |